The Food and Drug Administration has approved a new catheter designed to treat atrial flutter, a type of irregular heartbeat.
Abbott, which makes the catheter, said its FlexAbility Ablation Catheter, Sensor Enabled is its first to collect magnetic data and electrical current resistance to help accurately map out the sites in the heart that sustain or trigger abnormal heart rhythms.
"Sensor-enabled catheters, along with EnSite Precision cardiac mapping system, allow me to quickly identify and treat the arrhythmia, giving me the flexibility and accuracy I need to reach the most challenging locations in the heart to support effective outcomes and improve the lives of my patients," Dr. Jeffrey Winterfield, director of Ventricular Arrhythmia Service and associate professor of cardiac electrophysiology at the Medical University of South Carolina, said in a press release.
Abbott said the new catheter is also compatible with its MediGuide Technology, which allows physicians to reduce the duration of live X-rays during a procedure.
